Lars Rydén

21.0k total citations · 3 hit papers
161 papers, 6.7k citations indexed

About

Lars Rydén is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Lars Rydén has authored 161 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 94 papers in Endocrinology, Diabetes and Metabolism, 80 papers in Cardiology and Cardiovascular Medicine and 40 papers in Molecular Biology. Recurrent topics in Lars Rydén's work include Diabetes Treatment and Management (56 papers), Cardiovascular Function and Risk Factors (35 papers) and Metabolism, Diabetes, and Cancer (35 papers). Lars Rydén is often cited by papers focused on Diabetes Treatment and Management (56 papers), Cardiovascular Function and Risk Factors (35 papers) and Metabolism, Diabetes, and Cancer (35 papers). Lars Rydén collaborates with scholars based in Sweden, United Kingdom and Germany. Lars Rydén's co-authors include Hans Wedel, Klas Malmberg, Suad Efendić, Anna Norhammar, Anders Waldenström, Johan Herlitz, Peter Nicol, Lennart Welin, Linda Mellbin and John Öhrvik and has published in prestigious journals such as The Lancet, JAMA and Nature Medicine.

In The Last Decade

Lars Rydén

156 papers receiving 6.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): Effects on mortality at 1 year

1995 1.1k citations Klas Malmberg, Lars Rydén et al. Journal of the American College of Cardiology profile →
Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity

2005 728 citations Lars Rydén, Hans Wedel et al. European Heart Journal profile →
Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial

2024 102 citations Lars Rydén et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lars Rydén Sweden	41	3.9k	3.2k	1.3k	981	719	161	6.7k
Anna Norhammar Sweden	38	4.1k 1.1×	2.5k 0.8×	1.5k 1.2×	1.1k 1.1×	643 0.9×	133	6.1k
Søren Lund Kristensen Denmark	36	2.7k 0.7×	2.9k 0.9×	1.2k 0.9×	1.3k 1.3×	657 0.9×	134	6.4k
Peter Bramlage Germany	44	2.1k 0.5×	4.1k 1.3×	870 0.7×	1.7k 1.7×	1.2k 1.6×	464	7.7k
Aimun Ahmed United Kingdom	8	1.3k 0.3×	3.5k 1.1×	782 0.6×	1.2k 1.2×	494 0.7×	19	7.0k
Brendan M. Everett United States	36	1.6k 0.4×	2.2k 0.7×	931 0.7×	1.6k 1.7×	760 1.1×	91	5.2k
Richard J. MacIsaac Australia	46	2.8k 0.7×	1.1k 0.4×	783 0.6×	882 0.9×	655 0.9×	227	6.9k
Michael G. Silverman United States	22	4.5k 1.2×	2.0k 0.6×	1.9k 1.5×	2.6k 2.7×	523 0.7×	44	6.8k
Roberto Pontremoli Italy	42	1.4k 0.4×	2.5k 0.8×	659 0.5×	810 0.8×	700 1.0×	214	5.6k
João Pedro Ferreira France	45	4.0k 1.0×	5.3k 1.7×	1.3k 1.0×	1.7k 1.7×	560 0.8×	357	8.7k
María Lorenza Muiesan Italy	46	1.9k 0.5×	5.1k 1.6×	569 0.4×	1.3k 1.3×	439 0.6×	260	7.4k

Countries citing papers authored by Lars Rydén

Since Specialization

Citations

This map shows the geographic impact of Lars Rydén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Rydén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Rydén more than expected).

Fields of papers citing papers by Lars Rydén

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Rydén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Rydén. The network helps show where Lars Rydén may publish in the future.

Co-authorship network of co-authors of Lars Rydén

This figure shows the co-authorship network connecting the top 25 collaborators of Lars Rydén. A scholar is included among the top collaborators of Lars Rydén based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Rydén. Lars Rydén is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Backer, Guy De, John W. McEvoy, Catriona Jennings, et al.. (2025). Prevalence and prognostic importance of chronic kidney disease in patients with coronary heart disease: results from the combined EUROASPIRE IV and V studies. European Journal of Preventive Cardiology.

Gadler, Fredrik, Soffia Guðbjörnsdóttir, Stefan Franzén, et al.. (2024). Implantable cardioverter defibrillator and cardiac resynchronization treatment in people with type 2 diabetes: a comparison with age- and sex matched controls from the general population. Cardiovascular Diabetology. 23(1). 18–18.

Kanumilli, Naresh, Javed Butler, Konstantinos Makrilakis, et al.. (2023). Guardians For Health: A Practical Approach to Improving Quality of Life and Longevity in People with Type 2 Diabetes. Diabetes Therapy. 14(7). 1093–1110. 3 indexed citations

Bacquer, Dirk De, Felicity Astin, Kornelia Kotseva, et al.. (2021). Poor adherence to lifestyle recommendations in patients with coronary heart disease: results from the EUROASPIRE surveys. European Journal of Preventive Cardiology. 29(2). 383–395. 48 indexed citations

Bacquer, Dirk De, Catriona Jennings, Erkin М Мirrakhimov, et al.. (2021). Potential for optimizing management of obesity in the secondary prevention of coronary heart disease. European Heart Journal - Quality of Care and Clinical Outcomes. 8(5). 568–576. 9 indexed citations

Gerstein, Hertzel C., Ruth L. Coleman, Shishi Xu, et al.. (2020). Impact of Acarbose on Incident Diabetes and Regression to Normoglycemia in People With Coronary Heart Disease and Impaired Glucose Tolerance: Insights From the ACE Trial. Diabetes Care. 43(9). 2242–2247. 11 indexed citations

Marx, Nikolaus, Lars Rydén, Frank C. Brosius, et al.. (2020). Proceedings of the Guideline Workshop 2019: Strategies for the Optimization of Guideline Processes in Diabetes, Cardiovascular Diseases, and Kidney Diseases. Diabetes Technology & Therapeutics. 22(7). 546–552. 2 indexed citations

Gyberg, Viveca, Dirk De Bacquer, Kornelia Kotseva, et al.. (2016). Time-saving screening for diabetes in patients with coronary artery disease: a report from EUROASPIRE IV. BMJ Open. 6(12). e013835–e013835. 5 indexed citations

Kotseva, Kornelia, Lars Rydén, Guy De Backer, Dirk De Bacquer, & David Wood. (2015). CardioPulse Articles. European Heart Journal. 36(16). 950–955. 4 indexed citations

10.

Gyberg, Viveca, et al.. (2015). Accuracy of a Simplified Glucose Measurement Device—The HemoCue Glucose 201RT. Diabetes Technology & Therapeutics. 17(10). 755–758. 12 indexed citations

11.

Mohammad, Abdul‐Aleem, Afsar Rahbar, Weng‐Onn Lui, et al.. (2014). Detection of Circulating hcmv-miR-UL112-3p in Patients with Glioblastoma, Rheumatoid Arthritis, Diabetes Mellitus and Healthy Controls. PLoS ONE. 9(12). e113740–e113740. 32 indexed citations

12.

Johansson, Isabelle, Magnus Edner, Ulf Dahlström, et al.. (2013). Is the Prognosis in Patients with Diabetes and Heart Failure a Matter of Unsatisfactory Management? An Observational Study from the Swedish Heart Failure Registry. European Journal of Heart Failure. 16(4). 409–418. 39 indexed citations

13.

Jung, Christian, Peder Sörensson, Nawsad Saleh, et al.. (2011). Circulating endothelial and platelet derived microparticles reflect the size of myocardium at risk in patients with ST-elevation myocardial infarction. Atherosclerosis. 221(1). 226–231. 102 indexed citations

14.

Hage, Camilla, Linda Mellbin, Lars Rydén, & Jan Wernerman. (2010). Glucose Monitoring by Means of an Intravenous Microdialysis Catheter Technique. Diabetes Technology & Therapeutics. 12(4). 291–295. 10 indexed citations

15.

Landstedt‐Hallin, Lena, Klas Malmberg, A. Melcher, et al.. (2009). A Randomized Trial of the Impact of Strict Glycaemic Control on Myocardial Diastolic Function and Perfusion Reserve: A Report from the DADD (Diabetes Mellitus and Diastolic Dysfunction) Study. European Journal of Heart Failure. 11(1). 39–47. 58 indexed citations

16.

Mellbin, Linda, et al.. (2008). Prognostic implications of hypoglycaemic episodes during hospitalisation for myocardial infarction in patients with type 2 diabetes: a report from the DIGAMI 2 trial. Heart. 95(9). 721–727. 59 indexed citations

17.

Þráinsdóttir, Inga S., Thor Aspelund, Vilmundur Guðnason, et al.. (2007). Increasing Glucose Levels and BMI Predict Future Heart Failure Experience from the Reykjavík Study. European Journal of Heart Failure. 9(10). 1051–1057. 34 indexed citations

18.

Norhammar, Anna, Klas Malmberg, Erik Diderholm, et al.. (2004). Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization. Journal of the American College of Cardiology. 43(4). 585–591. 237 indexed citations

19.

Fuster, Valentı́n, Lars Rydén, Richard Asinger, et al.. (2001). Guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology. European Heart Journal. 22(20). 1852–1923. 374 indexed citations

20.

Rydén, Lars, et al.. (2000). European cardiology: 50 years. The Lancet. 356(9230). 671–672. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact